Virtu Financial LLC Silverback Therapeutics, Inc. Transaction History

Virtu Financial LLC

  • $1.43 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 20, 2024
BUY
N/A
20,201 New
20,201 $206,000
Q3 2023

Nov 14, 2023
BUY
N/A
80,816 New
80,816 $305,000
Q1 2023

May 01, 2023
BUY
N/A
10,411 New
10,411 $68,000
Q1 2022

May 17, 2022
SELL
$3.51 - $6.74 $71,312 - $136,936
-20,317 Closed
0 $0
Q4 2021

Feb 17, 2022
BUY
$6.03 - $11.67 $122,511 - $237,099
20,317 New
20,317 $135,000

Others Institutions Holding SBTX

# of Institutions
122
Shares Held
61.4M
Call Options Held
1.37M
Put Options Held
83.8K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email